PG(16:0/22:5(4Z,7Z,10Z,13Z,16Z))

Term ID

CHEBI:89090

Synonyms

1-Hexadecanoyl-2-(4Z,7Z,10Z,13Z,16Z-docosapentaenoyl)-sn-glycero-3-phospho-(1'-glycerol)
1-Hexadecanoyl-2-(7Z,10Z,13Z,16Z,19Z-docosapentaenoyl)-sn-glycero-3-phospho-(1'-glycerol)
1-Palmitoyl-2-docosapentaenoyl-sn-glycero-3-phosphoglycerol
1-Palmitoyl-2-osbondoyl-sn-glycero-3-phosphoglycerol
[(2S)-2,3-dihydroxypropoxy][(2R)-2-[(4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoyloxy]-3-(hexadecanoyloxy)propoxy]phosphinic acid
GPG(16:0/22:5)
GPG(16:0/22:5n6)
GPG(16:0/22:5w6)
GPG(38:5)
PG(16:0/22:5)
PG(16:0/22:5n6)
PG(16:0/22:5w6)
PG(38:5)
Phosphatidylglycerol(16:0/22:5)
Phosphatidylglycerol(16:0/22:5n6)
Phosphatidylglycerol(16:0/22:5w6)
Phosphatidylglycerol(38:5)

(all 17)

Definition

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from PG(16:0/22:5(4Z,7Z,10Z,13Z,16Z))

Phenotype where environments contain PG(16:0/22:5(4Z,7Z,10Z,13Z,16Z))

Phenotype modified by environments containing PG(16:0/22:5(4Z,7Z,10Z,13Z,16Z))

Phenotype affecting PG(16:0/22:5(4Z,7Z,10Z,13Z,16Z))

Human Disease Model